Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques

Chinese Medical Journal

Volumn 124, Issue 11, 2011, Pages 1657-1661

  Wang, Li Xin ^a   Lü, Shu Zheng ^a   Zhang, Wei jun ^a   Song, Xian Tao ^a   Chen, Hui ^b   Zhang, Li Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiography; Coronary artery stenosis; High sensitivity C reactive protein; Matrix metalloproteinase 9; Unstable angina

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PLAQUE; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PROTEIN BLOOD LEVEL; RELIABILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SMOKING;

EID: 79957918487     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.11.010     Document Type: Article

References (22)

1. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-1282.
2. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998; 97: 2110-2116.
3. Farb A, Tang AL, Burke AP, Sessums L, Liang YH, Virmani R. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 1995; 92: 1701-1709.
4. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-1275.
5. Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001; 16: 285-292.
6. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable angina pectoris. N Engl Med 2000; 342: 101-114.
7. Arbustini E, Dal Bello B, Morbini P, Burke A, Bocciarelli M, Specchia G, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82: 269-272.
8. Fuster V, Moreno PR, Zahi A, Fayad RC, Juan J. Atherothrombosis and high-risk plaque: Part I: Evolving concepts. J Am Coll Cardiol 2005; 46: 937-954.
9. Virmani R, Burke AP, Farb A, Frank D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: 937-954.
10. Farb A, Burke AP, Tang AL, Liang YH, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354-1363.
11. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
12. Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C. Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 2009; 206: 335-339.
13. Lijnen HR. Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemost Thromb 2003; 33: 275-281.
14. Johnson JL. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther 2007; 5: 265-282.
15. Danesh J, Wheeler JG, Hirschfidld GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive prorein and other circulating markers of inflammation in the prediction of coronary heart disease, N Engl J Med 2004; 350: 1387-1397.
16. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with rroponin T in acrte coronary syndromes: a TIMI 11 A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998; 31: 1460-1465.
17. Ridker PM, Buriing JE, Cook NR, Rifai N. C-reactive Protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8 year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391-397.
18. Hung MJ, Cherng WJ, Yang NI, Cheng CW, Li LF. Relation of highsensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 2005; 96: 1484-1490.
19. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation 1992; 85: 905-909.
20. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole R, Billinghurst RC, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99: 2503-2509.
21. Sluijter JPG, Pulskens WPC, Schoneveld AH, Velema E, Strijder CF, Moll F, et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions-a study in humanendarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 2006; 37: 235-239.
22. Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 2006; 69: 614-624.